GoldenGolden
Advanced Search
Merck Global Health Innovation Fund

Merck Global Health Innovation Fund

A Whitehouse Station-based venture capital firm that invests in emerging healthcare technology companies

Merck Global Health Innovation Fund is a venture capital firm in Whitehouse Station that prefers to invest in emerging healthcare technology companies. Founded 2010 in Whitehouse Station, New Jersey, the firm invests in Series B, Series D, Series C, and Series E rounds. The notable investment portfolio of Merck Global Health Innovation Fund includes PathAI, Navigating Cancer, Ciox Health, and GenomeDx Biosciences. As of January 2020, Merck Global Health Innovation Fund has made 57 investments and 14 exits. Their most recent investment was on Nov 4, 2019, when PathAI raised $15M.

Timeline

2010
Founded

People

Name
Role
LinkedIn

Dave Stevenson

Managing Director

David M. Rubin

Executive Director

Francesca Domenech Wuttke

Managing Director and Head of Venture Investments

Joe Volpe

Investment Principal

William Taranto

President

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Ciox Health

ClearDATA

electroCore

Livongo

Navigating Cancer

PathAI

Prognos

Strata Oncology

TriNetX

News

Title
Author
Date
Publisher
Description
Heather Landi
June 10, 2021
FierceHealthcare
Livongo founder Glen Tullman's latest venture has raised $58 million backed by major investors General Catalyst, Merck Global Health Innovation Fund, Kleiner Perkins and Bayer's corporate venture arm.
AbSci
February 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- AbSci, a pioneering synthetic biology company that unifies biologic drug discovery and development processes, today announced a strategic...
Walter Thompson
March 20, 2020
TechCrunch
I'm often asked as a long-time successful corporate venture capital investor to describe the strategies used to ensure our scale and staying power.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.